1 / 24

When Using DOPPS Slides

When Using DOPPS Slides. DOPPS Slide Use Guidelines. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and parathyroid hormone: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Introduction. DOPPS Background. Methods (1). Methods (2).

clodia
Download Presentation

When Using DOPPS Slides

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. When Using DOPPS Slides

  2. DOPPS Slide Use Guidelines

  3. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and parathyroid hormone: the Dialysis Outcomes and Practice Patterns Study (DOPPS)

  4. Introduction

  5. DOPPS Background

  6. Methods (1)

  7. Methods (2)

  8. Table 1. Study sample characteristics at baseline (1)

  9. Table 1. Study sample characteristics (2)

  10. Serum Calcium by country and DOPPS phase

  11. Serum Phosphorus by country and DOPPS phase

  12. PTH by country and DOPPS phase

  13. All-cause and cardiovascular mortality risk associated with baseline serum calcium

  14. All-cause and cardiovascular mortality risk associated with baseline serum phosphorus

  15. All-cause and cardiovascular mortality risk associated with baseline PTH

  16. Risk for all-cause and cardiovascular mortality associated with DOPPS-derived risk categories for serum calcium, phosphorus and PTH

  17. Patient mortality risk associated with 10% more facility patients within each serum PO4 category versus reference category (3.6-5.0 mg/dL)

  18. Risk of all-cause mortality associated with combinations of baseline serum phosphorus and calcium categories by PTH level

  19. Recommended mineral metabolism marker levels in Stage 5 CKD according to different professional organizations, and lowest mortality risk categories observed in the DOPPS

  20. Results (1)

  21. Results (2)

  22. Results (3)

  23. Conclusions

  24. Acknowledgements

More Related